ArisGlobal
↗Waltham, USA
ArisGlobal is a leading provider of cloud-based software solutions for the life sciences industry. The company specializes in automating core functions of the drug development lifecycle, including drug safety (pharmacovigilance), regulatory affairs, clinical research, and medical affairs, using its proprietary LifeSphere® platform powered by cognitive computing and AI.
Serving over 500 global life sciences companies, CROs, and government health authorities, ArisGlobal focuses on helping organizations accelerate drug development, maintain regulatory compliance, and streamline collaboration. The company is backed by private equity and has expanded its capabilities through strategic acquisitions and partnerships to provide a unified, end-to-end R&D technology suite.
CLASSIFICATION
Company Type:Digital Health
Therapeutic Areas:-
Industry:Digital Health
Sub-Industry:Life Sciences SaaS / RegTech
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$100M-$200M
Founded:1987
Ownership:subsidiary
Status:operating
FUNDING
Stage:Private Equity
Investors:Nordic Capital, Athyrium Capital Management, Abbhi Capital
0
CORPORATE STRUCTURE
Parent Company:Nordic Capital
Acquired By:Nordic Capital (2019-06-01)
Key Partnerships:Sitero LLC (Clinical trial solutions integration), Snowflake (Data ecosystem partnership)
COMPETITION
Position:Leader
Competitors:Owkin, Novotech, Atomwise, eClinical Solutions, Perceptive
LEADERSHIP
Key Executives:
Mike Gordon - CEO
Aman Wasan - Chief Commercial Officer
Rick Simpson - CFO
Board Members:Sankesh Abbhi, Dr. Amrit Ray, Eric Jensen
LINKS
Website:arisglobal.com
LinkedIn:LinkedIn Profile
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of ArisGlobal and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with ArisGlobal. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.